FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385190651> ?p ?o ?g. }

• W4385190651 endingPage "1080" @default.
• W4385190651 startingPage "1067" @default.
• W4385190651 abstract "Background: Sodium–glucose cotransporter-2 inhibitors (SGLT2is) decrease serum urate levels, but whether this translates into prevention of recurrent flares among patients with gout and gout-primary emergency department (ED) visits or hospitalizations is unknown. Objective: To compare gout flares and cardiovascular events among patients with gout initiating SGLT2is versus dipeptidyl peptidase 4 inhibitors (DPP-4is), another second-line glucose-lowering agent not associated with serum urate levels or cardiovascular risk. Design: Propensity score–matched, new-user cohort study. Setting: General population database from 1 January 2014 to 30 June 2022. Participants: Patients with gout and type 2 diabetes. Measurements: The primary outcome was recurrent gout flare counts ascertained by ED, hospitalization, outpatient, and medication dispensing records. Secondary outcomes included myocardial infarction and stroke; genital infection (positive control) and osteoarthritis encounter (negative control) were also assessed. Poisson and Cox proportional hazards regressions were used with 1:1 propensity score matching (primary analysis) and overlap weighting (sensitivity analysis). Results: After propensity score matching, the flare rate was lower among SGLT2i initiators than DPP-4i initiators (52.4 and 79.7 events per 1000 person-years, respectively), with a rate ratio (RR) of 0.66 (95% CI, 0.57 to 0.75) and a rate difference (RD) of −27.4 (CI, −36.0 to −18.7) per 1000 person-years. The corresponding RR and RD for gout-primary ED visits and hospitalizations were 0.52 (CI, 0.32 to 0.84) and −3.4 (CI, −5.8 to −0.9) per 1000 person-years, respectively. The corresponding hazard ratio (HR) and RD for myocardial infarction were 0.69 (CI, 0.54 to 0.88) and −7.6 (CI, −12.4 to −2.8) per 1000 person-years; the HR for stroke was 0.81 (CI, 0.62 to 1.05). Those who initiated SGLT2is showed higher risk for genital infection (HR, 2.15 [CI, 1.39 to 3.30]) and no altered risk for osteoarthritis encounter (HR, 1.07 [CI, 0.95 to 1.20]). Results were similar when propensity score overlap weighting was applied. Limitation: Participants had concurrent type 2 diabetes. Conclusion: Among patients with gout, SGLT2is may reduce recurrent flares and gout-primary ED visits and hospitalizations and may provide cardiovascular benefits. Primary Funding Source: National Institute of Arthritis and Musculoskeletal and Skin Diseases." @default.
• W4385190651 created "2023-07-25" @default.
• W4385190651 creator A5008925315 @default.
• W4385190651 creator A5040333432 @default.
• W4385190651 creator A5050486419 @default.
• W4385190651 creator A5058120562 @default.
• W4385190651 creator A5058955589 @default.
• W4385190651 creator A5076997901 @default.
• W4385190651 creator A5083145701 @default.
• W4385190651 creator A5084297561 @default.
• W4385190651 creator A5087655468 @default.
• W4385190651 date "2023-08-01" @default.
• W4385190651 modified "2023-10-15" @default.
• W4385190651 title "Comparative Effectiveness of Sodium–Glucose Cotransporter-2 Inhibitors for Recurrent Gout Flares and Gout-Primary Emergency Department Visits and Hospitalizations" @default.
• W4385190651 cites W1963805301 @default.
• W4385190651 cites W1966018233 @default.
• W4385190651 cites W2022503135 @default.
• W4385190651 cites W2022967311 @default.
• W4385190651 cites W2029668562 @default.
• W4385190651 cites W2062676246 @default.
• W4385190651 cites W2068029269 @default.
• W4385190651 cites W2072205603 @default.
• W4385190651 cites W2076691130 @default.
• W4385190651 cites W2100600407 @default.
• W4385190651 cites W2114136064 @default.
• W4385190651 cites W2114190104 @default.
• W4385190651 cites W2115269702 @default.
• W4385190651 cites W2121283103 @default.
• W4385190651 cites W2126049444 @default.
• W4385190651 cites W2126854279 @default.
• W4385190651 cites W2150169647 @default.
• W4385190651 cites W2150959326 @default.
• W4385190651 cites W2167491049 @default.
• W4385190651 cites W2335302945 @default.
• W4385190651 cites W2398128469 @default.
• W4385190651 cites W2411015075 @default.
• W4385190651 cites W2412212310 @default.
• W4385190651 cites W2510229455 @default.
• W4385190651 cites W2546951278 @default.
• W4385190651 cites W2580127675 @default.
• W4385190651 cites W2583236736 @default.
• W4385190651 cites W2608434441 @default.
• W4385190651 cites W2609605008 @default.
• W4385190651 cites W2619772777 @default.
• W4385190651 cites W2735301415 @default.
• W4385190651 cites W2749591576 @default.
• W4385190651 cites W2773337571 @default.
• W4385190651 cites W2781638103 @default.
• W4385190651 cites W2788029865 @default.
• W4385190651 cites W2793906475 @default.
• W4385190651 cites W2795806738 @default.
• W4385190651 cites W2888964504 @default.
• W4385190651 cites W2891073947 @default.
• W4385190651 cites W2894993577 @default.
• W4385190651 cites W2896170318 @default.
• W4385190651 cites W2901548733 @default.
• W4385190651 cites W2907932858 @default.
• W4385190651 cites W2913672674 @default.
• W4385190651 cites W2921856072 @default.
• W4385190651 cites W2940024069 @default.
• W4385190651 cites W2954291060 @default.
• W4385190651 cites W2972980198 @default.
• W4385190651 cites W2973090108 @default.
• W4385190651 cites W2981061670 @default.
• W4385190651 cites W2984471300 @default.
• W4385190651 cites W2996044601 @default.
• W4385190651 cites W2999396735 @default.
• W4385190651 cites W2999484966 @default.
• W4385190651 cites W3023814660 @default.
• W4385190651 cites W3033479545 @default.
• W4385190651 cites W3034485046 @default.
• W4385190651 cites W3036492313 @default.
• W4385190651 cites W3037804099 @default.
• W4385190651 cites W3038080478 @default.
• W4385190651 cites W3042176300 @default.
• W4385190651 cites W3047077524 @default.
• W4385190651 cites W3080857839 @default.
• W4385190651 cites W3089099811 @default.
• W4385190651 cites W3089732052 @default.
• W4385190651 cites W3092839557 @default.
• W4385190651 cites W3104282256 @default.
• W4385190651 cites W3111396502 @default.
• W4385190651 cites W3124074039 @default.
• W4385190651 cites W3164845562 @default.
• W4385190651 cites W3172996796 @default.
• W4385190651 cites W3199674324 @default.
• W4385190651 cites W3201795055 @default.
• W4385190651 cites W3203848658 @default.
• W4385190651 cites W3212211414 @default.
• W4385190651 cites W3213904373 @default.
• W4385190651 cites W4200191093 @default.
• W4385190651 cites W4200439235 @default.
• W4385190651 cites W4206946749 @default.
• W4385190651 cites W4210519182 @default.
• W4385190651 cites W4220884848 @default.
• W4385190651 cites W4224068676 @default.
• W4385190651 cites W4225508541 @default.
• W4385190651 cites W4229537562 @default.

• next